StonvexLoading…
StonvexCore line items from GEV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $38.07B | $34.94B | $33.24B | $29.65B |
Operating Income | $1.39B | $471.00M | $-923.00M | $-2.88B |
Net Income | $4.88B | $1.55B | $-438.00M | $-2.74B |
EPS (Diluted) | $17.69 | $5.58 | $-1.60 | $-10.00 |
Total Assets | $63.02B | $51.48B | $46.12B | Not available |
Total Liabilities | $50.72B | $40.89B | $37.74B | Not available |
Cash & Equivalents | $8.85B | $8.21B | $1.55B | $2.07B |
Free Cash Flow OCF − CapEx | $3.71B | $1.70B | $442.00M | $-627.00M |
Shares Outstanding | 269.53M | 275.88M | 274.00M | 274.00M |